🔎 Trials Near Me

ホーム › 白血病 › ニューヨーク

ニューヨークにおける白血病の臨床試験

ニューヨーク内の拠点で、白血病に関する26件の研究が参加者を募集しています。

ニューヨーク内の都市

公式研究テキスト(英語)

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 4, Buffalo
  • Quetzal Site 2, The Bronx
被験者募集中第3相
18歳〜71歳 · 全性別 · 2026/09/23更新 · NCT07504458

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • Montefiore Medical Center, New York
被験者募集中第1/2相
30 Days · 全性別 · 2026/09/16更新 · NCT04065399

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

  • Weill Cornell, New York
  • Clinical Research Allicance, Westbury
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT06824168

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/11更新 · NCT06229912

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

  • Columbia University Medical Center New York Presbyterian, New York
被験者募集中第2相
1歳〜18歳 · 全性別 · 2026/09/02更新 · NCT07354074

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  • State University of New York at Buffalo, Buffalo
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University, New York
  • 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Northwell Health, LLC PRIME, Lake Success
  • Memorial Sloan Kettering Cancer Center, New York
  • 他3件
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT06001788

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

  • Research Site, New York
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/08/19更新 · NCT06137118

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • New York Medical College, Valhalla
被験者募集中第1/2相
13歳〜90歳 · 全性別 · 2026/08/06更新 · NCT06533579

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

  • Albany Medical Center, Albany
被験者募集中観察研究
30歳以下 · 全性別 · 2026/07/16更新 · NCT04968834

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07216443

Hairy Cell Leukemia Patient Data Registry

  • University of Rochester /Wilmot Cancer Institute, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/02更新 · NCT02560883

Integrated Cancer Repository for Cancer Research

  • C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
  • Faxton St. Luke's Healthcare, Mohawk Valley, Utica
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699

CD4CAR for CD4+ Leukemia and Lymphoma

  • Albert Einstein Health Network, New York
被験者募集中第1相
12歳以上 · 全性別 · 2026/06/24更新 · NCT03829540

A Study of Revumenib and Mezigdomide in People With Leukemia

  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • 他1件
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/06/22更新 · NCT07356154

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

  • Dren Investigational Site 1, New York
  • Dren Investigational Site 2, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/17更新 · NCT05475925

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
  • Memorial Sloan Kettering Westchester (All protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All protocol activities), New York
  • 他1件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/05/26更新 · NCT07052916

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
  • University of Rochester, Rochester
  • Stony Brook University Medical Center, Stony Brook
  • 他1件
被験者募集中観察研究
全年齢 · 全性別 · 2026/05/18更新 · NCT01790152

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
被験者募集中第2相
26歳以下 · 全性別 · 2026/05/14更新 · NCT07566377

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • New York University Langone Hospital - Long Island, Mineola
  • Perlmutter Cancer Center - 34th Street, New York
  • 他2件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/04/30更新 · NCT04256317

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • New York - Presbyterian / Weill Cornell Medicine, New York
  • Mount Sinai - Ruttenberg Treatment Center, New York
  • 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/13更新 · NCT05735184

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • 他1件
被験者募集中観察研究健康なボランティア歓迎
全年齢 · 全性別 · 2026/01/23更新 · NCT00582621

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Buffalo
  • Massive Bio SYNERGY-AI site, Hempstead
  • Massive Bio SYNERGY-AI site, Manhasset
  • 他2件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/24更新 · NCT06501196

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。